MODIFICATION OF PHENYTOIN CLEARANCE BY VALPROIC ACID IN NORMAL SUBJECTS

被引:17
作者
FRIGO, GM
LECCHINI, S
GATTI, G
PERUCCA, E
CREMA, A
机构
关键词
D O I
10.1111/j.1365-2125.1979.tb01043.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The effect of valproic acid on the distribution and elimination kinetics of intravenously administered phenytoin has been investigated in eight normal volunteers. 2 In each of the subjects studied the volume of distribution of phenytoin increased significantly during treatment with sodium valproate (1200 mg daily for 7 days). 3 Phenytoin clearance was markedly increased in presence of valproic acid as compared to control values (0.52 +/‐ 0.17 v 0.38 +/‐ 0.11 ml min‐1 kg‐1 respectively, P less than 0.02). 4 It is suggested that the increase of the volume of distribution and of the serum clearance are secondary to displacement of phenytoin from plasma protein binding sites by valproic acid. 1979 The British Pharmacological Society
引用
收藏
页码:553 / 556
页数:4
相关论文
共 22 条
[11]   EFFECT OF PLASMA-PROTEIN BINDING ON ELIMINATION OF WARFARIN [J].
LEVY, G ;
YACOBI, A .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1974, 63 (05) :805-806
[12]   VALPROIC ACID IN EPILEPSY - CLINICAL AND PHARMACOLOGICAL EFFECTS [J].
MATTSON, RH ;
CRAMER, JA ;
WILLIAMSON, PD ;
NOVELLY, RA .
ANNALS OF NEUROLOGY, 1978, 3 (01) :20-25
[13]   PLASMA-PROTEIN BINDING INTERACTION BETWEEN PHENYTOIN AND VALPROIC ACID INVITRO [J].
MONKS, A ;
BOOBIS, S ;
WADSWORTH, J ;
RICHENS, A .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 6 (06) :487-492
[14]  
MONKS A, 1978, THESIS U LONDON
[15]  
MONKS A, CLIN PHARMAC THER
[16]   KINETICS OF DIPHENYLHYDANTOIN IN UREMIC PATIENTS - CONSEQUENCES OF DECREASED PLASMA-PROTEIN BINDING [J].
ODARCEDERLOF, I ;
BORGA, O .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1974, 7 (01) :31-37
[17]   EFFECT OF SODIUM VALPROATE ON PLASMA-PROTEIN BINDING OF DIPHENYLHYDANTOIN [J].
PATSALOS, PN ;
LASCELLES, PT .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1977, 40 (06) :570-574
[18]  
PERUCCA B, 1979, BRIT J CLIN PHARMAC, V7, pP414
[19]  
SCHULZ HU, 1977, ANN CLIN BIOCHEM, V14, P240
[20]  
SHAND DG, 1975, HDB EXPT PHARMACOLOG, V28, P272